SAT0468 Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients With Active Psoriatic Arthritis: Results From a Post Hoc Analysis From a Phase Iii Study

doi 10.1136/annrheumdis-2017-eular.1641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial

Arthritis Research & Therapy
2018English

Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”

Arthritis Research & Therapy
2019English

Longterm (52-Week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients With Psoriatic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2015English

Patient Background Factors Affecting the Therapeutic Outcomes in Response to Eszopiclone in Adult Patients With Chronic Insomnia: A Post Hoc Analysis of a Double-Blind Phase III Study in Japan

Journal of Clinical Sleep Medicine
PulmonaryNeurologyRespiratory Medicine
2015English

AB0794 Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Studies

2017English

The Effect of Psoriatic Arthritis on Ixekizumab Clinical Outcomes in Moderate-To-Severe Psoriasis Patients: A Post Hoc Analysis

Journal of the American Academy of Dermatology
Dermatology
2018English

Exploratory Study to Identify Mechanical Factors That May Contribute to Toe Dactylitis in Patients With Psoriatic Arthritis

Journal of Foot and Ankle Research
OrthopedicsSports Medicine
2014English

Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study

Arthritis Care and Research
Rheumatology
2019English

A Phase III Randomized Study to Evaluate the Efficacy and Safety of CT-P13 Compared With Reference Infliximab in Patients With Active Rheumatoid Arthritis: 54-Week Results From the PLANETRA Study

Arthritis Research & Therapy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy